DAFNA Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $764K | Sell |
51,096
-404
| -0.8% | -$6.04K | 0.21% | 61 |
|
|
2025
Q1 | $603K | Hold |
51,500
| – | – | 0.17% | 69 |
|
|
2024
Q4 | $1.18M | Buy |
51,500
+43,725
| +562% | +$1,000K | 0.3% | 54 |
|
|
2024
Q3 | $326K | Sell |
7,775
-3,225
| -29% | -$135K | 0.08% | 77 |
|
|
2024
Q2 | $400K | Buy |
+11,000
| New | +$400K | 0.1% | 74 |
|
|
2018
Q2 | – | Sell |
-5,396
| Closed | -$1.52M | – | 78 |
|
|
2018
Q1 | $1.52M | Sell |
5,396
-550
| -9% | -$155K | 0.74% | 39 |
|
|
2017
Q4 | $1.4M | Buy |
5,946
+1,969
| +50% | +$463K | 0.75% | 40 |
|
|
2017
Q3 | $1.13M | Buy |
+3,977
| New | +$1.13M | 0.7% | 42 |
|
|
2016
Q4 | – | Sell |
-1,000
| Closed | -$267K | – | 70 |
|
|
2016
Q3 | $267K | Buy |
+1,000
| New | +$267K | 0.19% | 63 |
|